Concepedia

Publication | Open Access

Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer

378

Citations

40

References

2016

Year

Abstract

Clinically informative genomic profiling of cfDNA was feasible in nearly all patients with mCRPC and can provide important insights into enzalutamide response and resistance.

References

YearCitations

Page 1